Therini Bio

Series-A
therinibio.com Biotech & Healthcare San Francisco, United States 1-10
Total Funding $56M
Latest Round Undisclosed Series-A
Last Announced May 21, 2026
Investors 9 Backers
Decision Makers 6 Verified

About Therini Bio

Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters San Francisco, United States
Team Size 1-10
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website therinibio.com
Domain Registered Date Nov 22, 2019

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Series-A announced

    fundraisingfox.com

  2. Capital Raise

    Raised $39,000,000 · Series-A

    Ophthalmology Times

  3. Capital Raise

    Raised $17,000,000 · Seed

  4. Milestone

    Website domain registered

    therinibio.com

Investors & Backers

9
Angelini Ventures
Apollo Health Ventures
Dementia Discovery Fund
Dolby Family Ventures
Eli Lilly
Foundation for a Better World
MRL Ventures Fund
Sanofi Ventures
SV Health Investors

Funding History

3 Rounds
Series-A · May 21, 2026
Series-A · May 19, 2025
Seed · May 10, 2021
$17,000,000 Source

Founders & Leadership

2

Dan Burgess

CEO

Work email & phone locked Unlock →

Katerina Akassoglou

Founder and Scientific Advisor

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts